This randomized controlled clinical trial aims to compare the clinical performance of zirconia-reinforced glass ionomer and injectable giomer restorations in Class V carious lesions among controlled type II diabetic against non-diabetics. One hundred Class V restorations will be allocated equally into four parallel groups according to restorative material and diabetic status. Clinical performance will be evaluated at baseline, 6, 12, and 18 months using the modified United States Public Health Service (USPHS) criteria. The primary outcome is restoration retention, while secondary outcomes include marginal adaptation, marginal discoloration, secondary caries, and postoperative sensitivity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
100
Zirconia-reinforced glass ionomer restorative material (SHOFU)
Injectable giomer restorative material incorporating S-PRG technology (SHOFU)
Restoration Retention
Restoration retention assessed using the modified USPHS criteria
Time frame: Baseline, 6 months, 12 months, and 18 months
Marginal adaptation
Using Modified USPHS Criteria
Time frame: Baseline, 6 months, 12 months, and 18 months
Marginal discoloration
Using Modified USPHS Criteria
Time frame: Baseline, 6 months, 12 months and 18 months
Secondary caries
Using Modified USPHS Criteria
Time frame: Baseline, 6 months, 12 months and 18 months.
Postoperative sensitivity
Using Modified USPHS Criteria
Time frame: Baseline, 6 months, 12 months and 18 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.